| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR204 |
|
microRNA 204
|
|
|
0.487 |
0.808 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| HPT |
|
hypoparathyroidism
|
|
|
0.593 |
0.692 |
| ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
| AGL |
P35573
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
Enzyme
|
2.8E-27 |
0.644 |
0.615 |
| NAT10 |
Q9H0A0
|
N-acetyltransferase 10
|
|
4.1E-22 |
0.536 |
0.769 |
| PLA2G7 |
Q13093
|
phospholipase A2 group VII
|
Enzyme
|
5.3E-22 |
0.537 |
0.769 |
| GPT |
P24298
|
glutamic--pyruvic transaminase
|
Enzyme
|
3.6E-19 |
0.403 |
0.923 |
| MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
| CFB |
P00751
|
complement factor B
|
|
4.7E-16 |
0.532 |
0.769 |
| AGER |
Q15109
|
advanced glycosylation end-product specific receptor
|
Receptor
|
6.4E-16 |
0.420 |
0.885 |
| NOS2 |
P35228
|
nitric oxide synthase 2
|
|
4.0E-15 |
0.364 |
0.923 |
| MPO |
P05164
|
myeloperoxidase
|
Enzyme
|
7.1E-15 |
0.377 |
0.923 |
| DECR1 |
Q16698
|
2,4-dienoyl-CoA reductase 1
|
Enzyme
|
4.5E-14 |
0.426 |
0.885 |
| ALPP |
P05187
|
alkaline phosphatase, placental
|
Enzyme
|
1.8E-13 |
0.487 |
0.808 |
| DYM |
Q7RTS9
|
dymeclin
|
|
3.6E-13 |
0.563 |
0.769 |
| GHRL |
Q9UBU3
|
ghrelin and obestatin prepropeptide
|
|
1.4E-11 |
0.517 |
0.769 |
| AOC3 |
Q16853
|
amine oxidase copper containing 3
|
|
6.3E-11 |
0.561 |
0.769 |
| PON1 |
P27169
|
paraoxonase 1
|
|
9.8E-11 |
0.409 |
0.885 |
| COL18A1 |
P39060
|
collagen type XVIII alpha 1 chain
|
|
1.7E-10 |
0.449 |
0.808 |
| MTHFR |
P42898
|
methylenetetrahydrofolate reductase
|
|
3.2E-10 |
0.337 |
0.885 |